Sector Alterity Therapeutics Limited Nasdaq
Stocks
ATHE
US02155X2053
Biotechnology & Medical Research
|
Delayed
Nasdaq
00:22:14 30/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 2.230 USD | +2.76% |
|
+3.72% | -27.60% |
| 10-05 | Alterity Therapeutics Limited Presents New Analyses of Ath434 Phase 2 Data in Multiple System Atrophy | CI |
| 09-16 | Lake Street Initiates Alterity Therapeutics at Buy With $10 Price Target | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.34% | -3.03% | -11.69% | +16.15% | +57.65% | +37.45% | +61.06% | +6.44% | - | 64.14B | |
| +0.98% | +2.68% | -5.19% | +3.71% | +12.22% | +12.25% | +83.90% | +210.70% | +5,645.71% | 55.53B | |
| +1.75% | +2.01% | +9.73% | +11.48% | +19.15% | +13.30% | +105.71% | -14.63% | +243.04% | 53.03B | |
| -1.44% | -1.13% | +2.30% | +11.15% | +22.08% | +26.32% | +55.32% | +5.26% | +283.57% | 45.99B | |
| -0.92% | -3.24% | +1.26% | +13.04% | +21.75% | +17.48% | +98.21% | +3.40% | +1,012.76% | 42.45B | |
| -0.17% | +0.47% | -7.78% | +4.23% | +136.75% | +225.02% | +927.66% | +540.76% | - | 40.45B | |
| -0.26% | -4.20% | +6.17% | +6.71% | +9.81% | +10.86% | +45.18% | +6.84% | +157.79% | 32.25B | |
| -2.07% | +42.73% | +63.49% | +102.89% | +86.88% | +103.77% | +90.26% | +31.35% | +238.82% | 34.47B | |
| -2.72% | -8.79% | -15.62% | +16.80% | +43.32% | +22.58% | -5.63% | -60.89% | - | 24.23B | |
| +0.27% | -1.66% | -10.54% | -5.13% | -7.37% | -14.67% | -5.43% | -68.36% | - | 22.1B | |
| +14.09% | +16.50% | -4.22% | +7.39% | -36.37% | -33.67% | +365.32% | +267.31% | +753.20% | 21.18B | |
| -1.51% | +4.50% | +9.85% | +16.84% | +21.68% | +16.91% | +182.63% | +201.66% | +2,254.94% | 19.38B | |
| +0.44% | +10.68% | +27.02% | +60.11% | +88.45% | +108.68% | +128.50% | -16.21% | +395.43% | 17.85B | |
| +0.97% | +4.59% | +14.28% | +26.86% | +39.55% | +43.70% | +86.35% | -14.58% | +110.39% | 16.69B | |
| -0.60% | +0.75% | +12.19% | +18.92% | +50.13% | +66.88% | +225.10% | +205.90% | +521.34% | 16.42B | |
| +0.31% | +3.21% | +9.96% | -0.50% | - | - | - | - | - | 16.39B | |
| +3.33% | +5.53% | +7.36% | +11.21% | +192.66% | +175.10% | +360.46% | +1,478.53% | +825.12% | 15.33B | |
| +1.17% | +17.18% | +27.55% | +21.95% | +19.24% | +30.93% | -8.75% | -24.23% | +170.66% | 16.04B | |
| +0.97% | -7.48% | -3.82% | -13.90% | +11.63% | +3.79% | +468.94% | - | - | 13.21B | |
| Average | +0.77% | +3.86% | +6.96% | +17.36% | +43.85% | +48.15% | +181.38% | +162.31% | +970.21% | 29.85B | |
| Weighted average by Cap. | +0.48% | +3.36% | +4.92% | +17.27% | +42.10% | +46.49% | +168.89% | +123.90% | +1,262.82% |
- Stock Market
- Stocks
- ATH Stock
- ATHE Stock
- Sector Alterity Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
